Comments
Loading...
AbCellera Biologics (ABCL) Forecast
NewsEarningsAbCellera Biologics (ABCL) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestAbCellera Biologics (NASDAQ:ABCL) Stock Quotes, Forecast and News Summary
AbCellera Biologics Stock (NASDAQ: ABCL) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy AbCellera Biologics (ABCL) stock?
You can purchase shares of AbCellera Biologics (NASDAQ:ABCL) through any online brokerage.
Who are AbCellera Biologics (ABCL) competitors?
There are no as such competitors for AbCellera Biologics.
What is the forecast, or price target, for AbCellera Biologics (ABCL) stock?
AbCellera Biologics has a consensus price target of $21.00.
What is the current price for AbCellera Biologics (ABCL)?
The stock price for AbCellera Biologics (NASDAQ: ABCL) is $3.295 last updated January 30, 2025 at 12:19 PM EST.
Does AbCellera Biologics (ABCL) pay a dividend?
There are no upcoming dividends for AbCellera Biologics.
When is AbCellera Biologics (NASDAQ:ABCL) reporting earnings?
AbCellera Biologics’s Q4 earnings are confirmed for Thursday, February 27, 2025.
Is AbCellera Biologics (ABCL) going to split?
There is no upcoming split for AbCellera Biologics.
What sector and industry does AbCellera Biologics (ABCL) operate in?
AbCellera Biologics is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.